Statistically significant lower risk is seen for cases and viral clearance. 2 studies (both from the same team) show significant improvements.
Meta analysis using the most serious outcome reported shows 49% [-60‑84%] lower risk, without reaching statistical significance.
Currently there is limited data, with only 345 patients in trials to date. All studies to date are from the same group.
No treatment or intervention is 100% effective. All practical, effective, and safe means should be used based on risk/benefit analysis. Multiple treatments are typically used in combination, and other treatments may be more effective. There has been no early treatment studies to date.
All data to reproduce this paper and sources are in the appendix.
Covid Analysis et al., May 2024, preprint, 1 author.